CXCL9 and colitis: At the molecular level, CXCL9 has been shown to inhibit the reconstitution of the intestinal mucosa after injury (Lu et al., 2015) and to control E. coli overgrowth through the pyruvate dehydrogenase-encoding aceE gene in a DSS-induced colitis model (Wei et al., 2022).